Abstract
Atrial fibrillation is the most common cardiac arrhythmia and is a major cause of embolic stroke. In patients at high bleeding risk such as those with hemophilia, the thromboembolic prevention is challenging. We herein present three patients affected by moderate to severe hemophilia and atrial fibrillation that were treated in our Institution between March 2018 and September 2019, with percutaneous left atrial appendage closure. In patients with relative or absolute contraindications to long-term anticoagulant therapy, the left atrial appendage closure could represent a reasonable strategy.
This is a preview of subscription content, log in via an institution to check access.
References
Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22(8):983–988. https://doi.org/10.1161/01.STR.22.8.983
Plug I, Van Der Bom JG, Peters M et al (2006) Mortality and causes of death in patients with hemophilia, 1992–2001: a prospective cohort study1. J Thromb Haemost 4(3):510–516. https://doi.org/10.1111/j.1538-7836.2006.01808.x
Darby SC, Kan SW, Spooner RJ et al (2007) Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood 110(3):815–825. https://doi.org/10.1182/blood-2006-10-050435
Mannucci PM, Schutgens REG, Santagostino E, Mauser-Bunschoten EP (2009) How I treat age-related morbidities in elderly persons with hemophilia. Blood 114(26):5256–5263. https://doi.org/10.1182/blood-2009-07-215665
Schutgens REG, Klamroth R, Pabinger I, Malerba M, Dolan G, the ADVANCE Working Group (2014) Atrial fibrillation in patients with haemophilia: a cross-sectional evaluation in Europe. Haemophilia 20(5):682–686. https://doi.org/10.1111/hae.12445
Friberg L, Rosenqvist M, Lip GYH (2012) Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J 33(12):1500–1510. https://doi.org/10.1093/eurheartj/ehr488
Kirchhof P, Benussi S, Kotecha D et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37(38):2893–2962. https://doi.org/10.1093/eurheartj/ehw210
Blackshear JL, Odell JA (1996) Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 61(2):755–759. https://doi.org/10.1016/0003-4975(95)00887-X
Meier B, Blaauw Y, Khattab AA et al (2014) EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. EP Europace 16(10):1397–1416. https://doi.org/10.1093/europace/euu174
Michael Glikson, Rafael Wolff, Gerhard Hindricks, et al. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion—an update. EuroIntervention. August 2019. https://eurointervention.pcronline.com/article/ehra-eapci-expert-consensus-statement-on-catheter-based-left-atrial-appendage-occlusion-an-update.
Güray Ü, Korkmaz A, Gürsoy HT, Elalmış ÖU (2019) Percutaneous left atrial appendage closure in a patient with haemophilia and atrial fibrillation: a case report. Eur Heart J Case Rep. 3(3):ytz124. https://doi.org/10.1093/ehjcr/ytz124
Schutgens REG, van der Heijden JF, Mauser-Bunschoten EP, Mannucci PM (2016) New concepts for anticoagulant therapy in persons with hemophilia. Blood 128(20):2471–2474. https://doi.org/10.1182/blood-2016-07-727032
Boehnel C, Rickli H, Graf L, Maeder MT (2018) Coronary angiography with or without percutaneous coronary intervention in patients with hemophilia—systematic review. Catheter Cardiovasc Interv 92(1):1–15. https://doi.org/10.1002/ccd.27255
Cheung VTF, Hunter RJ, Ginks MR, Schilling RJ, Earley MJ, Bowles L (2013) Management of thromboembolic risk in persons with haemophilia and atrial fibrillation: is left atrial appendage occlusion the answer for those at high risk? Haemophilia 19(2):e84–e86. https://doi.org/10.1111/hae.12055
Bhatti Z, Goldbarg S (2019) Combined left atrial appendage closure and ablation in a patient with hemophilia B, paroxysmal atrial fibrillation, and transient ischemic attack. HeartRhythm Case Rep 5(5):266–268. https://doi.org/10.1016/j.hrcr.2019.01.014
Funding
The authors have no funding to declare.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were conducted in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study. The author/s confirm that written consent for submission and publication of this case report including image(s) and associated text has been obtained from the patients, when applicable, in line with COPE guidance.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Toselli, M., Bosi, D., Benatti, G. et al. Left atrial appendage closure: a balanced management of the thromboembolic risk in patients with hemophilia and atrial fibrillation. J Thromb Thrombolysis 50, 668–673 (2020). https://doi.org/10.1007/s11239-020-02097-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-020-02097-5